BMPER Antibody is a specialized immunological reagent designed to detect the bone morphogenetic protein (BMP) endothelial cell precursor-derived regulator (BMPER) protein. It facilitates the study of BMPER’s localization, expression levels, and functional interactions in biological systems. These antibodies are critical for understanding BMPER’s role in vascular development, inflammation, and disease pathologies.
Key applications include:
Immunocytochemistry/Immunofluorescence: To map BMPER distribution in tissues or cells.
Western Blotting: To quantify BMPER protein expression in lysates.
Immunohistochemistry: To analyze BMPER in tissue sections.
In embryonic studies, the Mouse Crossveinless-2/CV-2 Antibody (AF2299) from R&D Systems has been used to visualize BMPER in the aorta-gonad-mesonephros (AGM) region of mouse embryos . This antibody detects BMPER in perivascular cells and subaortic mesenchyme, showing spatial complementarity with phosphorylated Smad1/5/8 (pSMAD1/5/8), a marker of BMP signaling .
BMPER expression peaks in the AGM region during hematopoietic development.
Localization patterns suggest BMPER negatively regulates BMP signaling via feedback inhibition .
The Anti-BMPER Antibody (ab75183) from Abcam has been employed to study BMPER downregulation in renal fibrosis. In unilateral ureteral obstruction (UUO) models, Western blotting revealed reduced BMPER expression in kidneys and TGF-β1-treated HK-2 tubular cells .
BMPER levels inversely correlate with fibrosis markers (e.g., fibronectin, collagen I).
Exogenous BMPER administration mitigates tubular dedifferentiation and fibroblast activation .
BMPER antibodies have clarified BMPER’s dual role as a BMP antagonist and modulator. For instance:
Negative Feedback on BMP Signaling: AF2299 staining in mouse embryos demonstrated that BMPER-rich regions exhibit reduced pSMAD1/5/8, indicating suppression of BMP activity .
Context-Dependent Activity: While BMPER inhibits BMP4 in some contexts, its loss exacerbates vascular inflammation by upregulating adhesion molecules (e.g., VCAM-1, ICAM-1) .
In kidney fibrosis models, BMPER antibodies revealed its protective role:
| Model | BMPER Antibody Used | Observed Effect | Citation |
|---|---|---|---|
| UUO Mice | ab75183 (Abcam) | Reduced fibronectin and collagen I | |
| TGF-β1-Treated HK-2 Cells | ab75183 (Abcam) | Inhibited E-cadherin loss and Id1 upregulation |
| Antibody Name (Catalog Number) | Manufacturer | Species | Application | Key Features |
|---|---|---|---|---|
| Mouse Crossveinless-2/CV-2 (AF2299) | R&D Systems | Mouse | Immunocytochemistry, Immunofluorescence | Detects perivascular BMPER; quantifies pSMAD1/5/8 complementarity |
| Anti-BMPER (ab75183) | Abcam | Human | Western Blotting | Validates BMPER downregulation in fibrosis |